On Friday, Following U.S. Stocks were among the “Top Losers“: Goodrich Petroleum Corporation (NYSE:GDP), Warren Resources, Inc (NASDAQ:WRES), Continental Resources, Inc (NYSE:CLR), Akorn, Inc (NASDAQ:AKRX)
Goodrich Petroleum Corporation (NYSE:GDP)’s shares dwindled -4.98%, and closed at $2.86. The company holds the market capitalization of 163.33M. For the trailing twelve months, the stock’s return on assets value is -187.10%, in response to its return on investment value of - 41.30%. Its 20-day moving average declined -25.41%, below 50-day moving average of -15.81%, above 200-day moving average of -78.12% from the latest market price of $2.86. The mean recommendation of analysts for this stock is 3.00.(where 1=Buy, 5=Sale).
Goodrich Petroleum Corporation, an independent oil and natural gas company, engages in the exploration, development, and production of oil and natural gas. The company holds interest in the Tuscaloosa Marine Shale located in southwest Mississippi and southeast Louisiana; the Eagle Ford Shale Trend located in South Texas; and the Haynesville Shale Trend in Northwest Louisiana and East Texas. It owns working interests in 260 producing oil and natural gas wells located in 43 fields in 8 states. As of December 31, 2014, the company had estimated proved reserves of about 273.7 billion cubic feet equivalent comprising 104.8 billion cubic feet of natural gas, 1.0 million barrels of crude oil or other liquid hydrocarbons (MMBbls) of natural gas liquids, and 27.1 MMBbls of oil and condensate.
Warren Resources, Inc (NASDAQ:WRES), declined -4.95%, and closed at $1.05. The stock has price to sale value of 0.57, however, price to book value is 0.29. With recent decline, the year-to-date (YTD) performance reflected a -34.47% declined below last year. During the past month the stocks lose -76.29%, bringing three-month performance to -24.10% and six-month performance to -82.15%. The mean recommendation of analysts for this stock is 3.00. (where 1=Buy, 5=Sale).
Warren Resources, Inc., an independent energy company, engages in the exploration, development, and production of domestic onshore crude oil and gas reserves. The company primarily focuses on the exploration and development of waterflood oil recovery projects in the Wilmington field within the Los Angeles Basin of California; Marcellus Shale project in northeastern Pennsylvania; and coalbed methane natural gas properties located in the Rocky Mountain region.
Continental Resources, Inc (NYSE:CLR), dipped -4.88%, and closed at $41.30. The company has the market capitalization of $15.36B. In the last trading session 6.88M shares changed hands as compared to its average volume of 4.35M shares. The beta value of the stock is 1.37. On the other hand the stock’s volatility for the week is 3.94%, and for the month is 4.25%. The stock price to book value is $3.07, however price to sale value is $3.20. Analyst’s mean recommendation regarding this stock is 2.50. (where 1=Buy, 5=Sale).
Continental Resources, Inc. explores, develops, and produces crude oil and natural gas properties in the north, south, and east regions of the United States. The company sells its crude oil production to end users, in addition to midstream marketing companies or crude oil refining companies at the lease. As of December 31, 2014, its estimated proved reserves were 1,351 million barrels of crude oil equivalent (MMBoe), with estimated proved developed reserves of 502 MMBoe. Continental Resources, Inc. was founded in 1967 and is headquartered in Oklahoma City, Oklahoma.
Akorn, Inc (NASDAQ:AKRX), dropped -4.84%, and closed at $41.28. The stock volatility for the week is 8.12%, while for the month remained 5.07%. The company holds consensus target price of $57.85.
If we consider EPS growth of the company, then we will notice the following observations:
The company showed 0.32 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained -26.10% and Annual EPS growth for the past 5 years is considered as 26.30%.
The mean recommendation of analysts for this stock is 1.90. (where 1=Buy, 5=Sale).
Akorn, Inc. manufactures and markets diagnostic and therapeutic ophthalmic pharmaceuticals, niche hospital drugs, and injectable pharmaceuticals in the United States and internationally. It offers products in various areas, counting ophthalmology, antidotes, anti-infectives, pain administration, anesthesia, vaccines, and others. The company operates in three segments: Ophthalmic, Hospital Drugs & Injectables, and Contract Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
